These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities. Lattanzi R; Spetea M; Schüllner F; Rief SB; Krassnig R; Negri L; Schmidhammer H J Med Chem; 2005 May; 48(9):3372-8. PubMed ID: 15857143 [TBL] [Abstract][Full Text] [Related]
11. Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists. Coats SJ; Schulz MJ; Carson JR; Codd EE; Hlasta DJ; Pitis PM; Stone DJ; Zhang SP; Colburn RW; Dax SL Bioorg Med Chem Lett; 2004 Nov; 14(22):5493-8. PubMed ID: 15482911 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2). Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors. Peng X; Knapp BI; Bidlack JM; Neumeyer JL J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810 [TBL] [Abstract][Full Text] [Related]
14. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan. Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100 [TBL] [Abstract][Full Text] [Related]
15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model. Zhao M; Wang JY; Jia H; Tang JS Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416 [TBL] [Abstract][Full Text] [Related]
16. Identification of potent phenyl imidazoles as opioid receptor agonists. Breslin HJ; Cai C; Miskowski TA; Coutinho SV; Zhang SP; Hornby P; He W Bioorg Med Chem Lett; 2006 May; 16(9):2505-8. PubMed ID: 16483774 [TBL] [Abstract][Full Text] [Related]
17. N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models. Jones P; Griffin AM; Gawell L; Lavoie R; Delorme D; Roberts E; Brown W; Walpole C; Xiao W; Boulet J; Labarre M; Coupal M; Butterworth J; St-Onge S; Hodzic L; Salois D Bioorg Med Chem Lett; 2009 Nov; 19(21):5994-8. PubMed ID: 19800791 [TBL] [Abstract][Full Text] [Related]
18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929 [TBL] [Abstract][Full Text] [Related]
19. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H. Gallantine EL; Meert TF Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797 [TBL] [Abstract][Full Text] [Related]
20. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol. Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]